<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pontremoli M</submitter><funding>Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute</funding><funding>Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute (Italian Medicines Agency)</funding><pagination>16671</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6232108</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>This study shows that DKK-1, a member of the Dickkopf family and a regulator of the Wnt pathways, represents a novel target of statins which, through the inhibition of HMG-CoA reductase and of non-steroidal isoprenoid intermediates, exert extra-beneficial effect in preventing atherosclerosis beyond their effect on the lipid profile. We found that atorvastatin downregulates DKK-1 protein (-88.3 ± 4.1%) and mRNA expression (-90 ± 4.2%) through the inhibition of Cdc42, Rho and Rac geranylgeranylated proteins. Further, a combined approach based on the integration of label-free quantitative mass spectrometry based-proteomics and gene silencing allowed us to demonstrate that DKK-1 itself mediates, at least in part, statin effects on human endothelial cells. Indeed, DKK-1 is responsible for the r</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells.</pubmed_title><pmcid>PMC6232108</pmcid><funding_grant_id>2101581</funding_grant_id><pubmed_authors>Baetta R</pubmed_authors><pubmed_authors>Banfi C</pubmed_authors><pubmed_authors>Pontremoli M</pubmed_authors><pubmed_authors>Brioschi M</pubmed_authors><pubmed_authors>Ghilardi S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells.</name><description>This study shows that DKK-1, a member of the Dickkopf family and a regulator of the Wnt pathways, represents a novel target of statins which, through the inhibition of HMG-CoA reductase and of non-steroidal isoprenoid intermediates, exert extra-beneficial effect in preventing atherosclerosis beyond their effect on the lipid profile. We found that atorvastatin downregulates DKK-1 protein (-88.3 ± 4.1%) and mRNA expression (-90 ± 4.2%) through the inhibition of Cdc42, Rho and Rac geranylgeranylated proteins. Further, a combined approach based on the integration of label-free quantitative mass spectrometry based-proteomics and gene silencing allowed us to demonstrate that DKK-1 itself mediates, at least in part, statin effects on human endothelial cells. Indeed, DKK-1 is responsible for the r</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Nov</publication><modification>2026-05-06T01:03:16.811Z</modification><creation>2019-03-27T00:10:15Z</creation></dates><accession>S-EPMC6232108</accession><cross_references><pubmed>30420710</pubmed><doi>10.1038/s41598-018-35119-7</doi></cross_references></HashMap>